logo
Whataburger® Saddles Up with the New Bacon Wrangler Double: A Burger as Big and Bold as the Lone Star State

Whataburger® Saddles Up with the New Bacon Wrangler Double: A Burger as Big and Bold as the Lone Star State

Grab your Boots - the Bacon Wrangler Double Arrives Aug. 5 for a Limited Time Only
SAN ANTONIO, July 21, 2025 /PRNewswire/ -- The Lone Star State doesn't do anything halfway – and neither does Whataburger. Say howdy to the all-new Bacon Wrangler Double, a burger so bold, so proud and so over-the-top delicious, it just might be the most Texas thing on a toasted bun.
Available on Aug. 5, the Bacon Wrangler Double stacks two fresh, 100% American beef patties with bacon, Monterey Jack and American cheeses, pickles, crispy onion strings and chipotle aioli – all layered between toasted buns built for big appetites. Inspired by the legendary wranglers who shaped the Wild West, this burger packs a chipotle kick and smoky, char-grilled flavors that holler Texas from the back of a pickup under the fireworks at the rodeo.
'As a proud Texas-born brand, Whataburger was built on bold flavors, genuine hospitality and a spirit that feels like home,' said Whataburger President and CEO Debbie Stroud. 'For 75 years, we've brought that taste to communities across the country, serving up high quality, delicious food that celebrate our roots through flavor and freshness. The Bacon Wrangler Double is a delicious reminder that you can always experience a little bit of that spirit with every bite.'
And here's the kicker: you don't have to be out on the range to feel like you are. One bite and it's boots on, sky wide and big flavor driving the whole thing home. So saddle up! The Bacon Wrangler Double won't be around forever, so grab it before it rides off into the sunset.
Hungry for more? Whataburger has fans covered 24/7 - whether they swing through the drive-thru, order online or tap into the Whataburger App. Guests who download the app and create an account start earning points to spend toward their go-to favorites and automatically earn a free Whataburger. Now that's how you Texas.
Visit Whataburger.com for further details.
About Whataburger®
Whataburger serves up Goodness 24/7 with a made-to-order, customizable menu of burgers and other favorites delivered just like you like it. Born in Texas and headquartered in San Antonio, we're celebrating 75 flavorful years of big bites, bold flavors, and even bigger fan love. We've grown to over 1,100 restaurants across 17 states, with original-recipe products now found in grocery aisles across the country. Our secret sauce (besides that Fancy Ketchup) is our Family Members—real people serving up real hospitality and meaningful connections in the communities we call home. We've landed on Fast Company's Brands that Matter list, USA Today's 10Best Readers' Choice Awards, and Newsweek's America's Best of the Best. To learn more, shop the Whatastore, or find your nearest location, visit Whataburger.com – or download our app on iOS or Android. Hungry for more? Discover what keeps fans coming back by diving into real stories from Whataburger super fans at stories.whataburger.com.
For media inquiries, please contact:
Whataburger PR
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/whataburger-saddles-up-with-the-new-bacon-wrangler-double-a-burger-as-big-and-bold-as-the-lone-star-state-302509823.html
SOURCE Whataburger
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Yahoo

time7 minutes ago

  • Yahoo

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

The Open Group Launches The Open Group Open Digital Transformation™ Forum
The Open Group Launches The Open Group Open Digital Transformation™ Forum

Yahoo

time7 minutes ago

  • Yahoo

The Open Group Launches The Open Group Open Digital Transformation™ Forum

Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Yahoo

time7 minutes ago

  • Yahoo

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store